Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05820139 · ClinicalTrials.gov registry record · NA
Evaluating the Optimal Volume Voided for Passage of a Backfill-Assisted Voiding Trial Following Urogynecologic Surgery
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT05820139 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 100 participants.
The verdict
NCT05820139, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Urinary retention can lead to bladder over-distention, ischemia, and long-term voiding dysfunction, and early identification of urinary retention can help prevent these adverse events
Interventions
- PROCEDURE Control Group
- PROCEDURE Test Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-07-11 |
| Est. Completion | 2024-02-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05820139
The ClinicalTrials.gov registry entry for NCT05820139 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Group is the first listed.
NCT05820139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05820139 about?
NCT05820139 is a clinical study titled "Evaluating the Optimal Volume Voided for Passage of a Backfill-Assisted Voiding Trial Following Urogynecologic Surgery". Urinary retention can lead to bladder over-distention, ischemia, and long-term voiding dysfunction, and early identification of urinary retention can help prevent these adverse events
What is the current status of trial NCT05820139?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2023-07-11. Estimated completion is 2024-02-26.
What interventions are being tested in trial NCT05820139?
The interventions under investigation include: Control Group (PROCEDURE), Test Group (PROCEDURE).
Who is sponsoring clinical trial NCT05820139?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.